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Abstract - (243) 
We recently introduced an animal model to study incubation of drug craving after prolonged 
voluntary abstinence, mimicking the human condition of relapse after successful contingency 
management treatment. Here we studied the role of the nucleus accumbens (NAc) in this model. 
We trained rats to self-administer a palatable solution (sucrose+maltodextrin 1%, 6 h/day, 6 days) 
and methamphetamine (6 h/day, 12 days). We then evaluated relapse to methamphetamine seeking 
after 1 and 15 days of voluntary abstinence, achieved via a discrete choice procedure between the 
palatable solution and methamphetamine (14 days). We used RNAscope in-situ hybridization to 
quantify the co-labeling of the neuronal activity marker Fos, and dopamine Drd1- and Drd2-
expressing medium spiny neurons (MSNs) in NAc core and shell during the incubation tests. Next, we 
determined the effect of pharmacological inactivation of NAc core and shell by either GABAA and 
GABAB agonists (muscimol+baclofen, 50+50 ng/side), Drd1-Drd2 antagonist (flupenthixol, 10 µg/side) 
or the selective Drd1 or Drd2 antagonists (SCH39166 1.0 µg/side or raclopride 1.0 µg/side) during the 
relapse tests.  
Incubated methamphetamine seeking after voluntary abstinence was associated with a selective 
increase of Fos expression in the NAc core, but not shell, and Fos was co-labeled with both Drd1- 
and Drd2-MSNs. NAc core, but not shell, injections of muscimol+baclofen, flupenthixol, SCH39166, 
and raclopride reduced methamphetamine seeking after 15 days of abstinence.  
Together, our results suggest that dopamine transmission through Drd1 and Drd2 in NAc core is 
critical to the incubation of methamphetamine craving after voluntary abstinence. 
 
Key words: methamphetamine, self-administration, contingency management, relapse, palatable 
food, nucleus accumbens, dopamine receptor, Fos 
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Introduction (628 words) 
Despite decades of research on the neurobiological mechanisms of psychostimulant addiction, 
the only effective treatments are based on behavioral intervention strategies which harnesses operant 
principles to promote voluntary abstinence [1,2]. One of these methods is contingency management 
in which drug abstinence is reinforced and maintained via delivery of alternative incentives (e.g., 
monetary vouchers) [3]. However, when contingency management is discontinued most addicts 
relapse to drug use [4,5]. 
At present, the brain mechanisms underlying relapse after cessation of contingency management 
are unknown. Based on the seminal studies of Lenoir et al., [6] and Ahmed et al., [7], showing that 
most rats prefer palatable food over cocaine in a discrete choice setting, we recently introduced a 
choice-based rat model of relapse after voluntary abstinence [8]. In this procedure, we first trained 
food-sated rats to self-administer palatable food (the alternative nondrug reward) and then 
methamphetamine for several weeks. We then assessed relapse to drug seeking at an early and late 
abstinence day. Between methamphetamine self-administration and the test on late abstinence day, 
rats were exposed to daily mutually exclusive choice sessions between the drug and palatable food 
[9]. Under these ‘contingency management’ conditions, like human addicts, male and female rats 
choose to abstain from methamphetamine or heroin [8,10,11]. However, after discontinuing the 
palatable food, the rats’ drug seeking response progressively increased during abstinence. This 
phenomenon, termed ‘incubation of drug craving’, was first observed after home cage forced 
abstinence conditions in rats trained to self-administer cocaine [12], and subsequently with other 
abused drugs [13,14]. Evidences of this phenomenon are also available in humans for nicotine [15], 
methamphetamine [16], alcohol [17,18] and cocaine [19]. 
In our initial mechanistic characterization of the choice-based rat model of relapse, we identified: 
1) a critical role of dopamine receptor 1-expressing (Drd1) neurons in the CeA and the glutamatergic 
projection from anterior insular cortex to central amygdala [20] in relapse to methamphetamine 
seeking after voluntary abstinence; 2) a critical role of dorsomedial striatum neuronal ensembles, in 
incubation of methamphetamine craving after voluntary abstinence [10]. In the current study, we 
assessed the role of nucleus accumbens (NAc) subregions (core and shell) in incubation of 
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methamphetamine craving after food choice-induced voluntary abstinence. Anatomically, the NAc 
core and shell are distinguished on the basis of the morphology and projections although both 
subregions are primarily constituted of two neuronal populations: dopamine receptors Drd1- and 
Drd2-expressing medium spiny neurons (MSNs) that further differ in the neuropeptide expression 
profile [21].  
We studied the NAc core because previous studies showed that incubated cocaine craving after 
forced abstinence is associated with an altered firing in this area [22,23]. Furthermore, incubated 
cocaine and methamphetamine craving after forced abstinence is reduced by inhibiting calcium-
permeable AMPA receptor (CP-AMPARs) transmission in NAc core [24-26] or, for cocaine, via 
weakening the prelimbic cortex to NAc core pathway [27].  
We studied the role of the NAc shell because, similarly to the core subregion, increased CP-
AMPARs transmission is also evident after prolonged abstinence from cocaine self-administration 
[27-30]. Furthermore, incubated cocaine craving is reduced by selectively weakening the basolateral 
amygdala to NAc shell pathway [31], or simultaneous weakening of the infralimbic to Drd1-MSNs 
shell and ventral hippocampus to Drd1-MSNs shell pathways [32]. 
In the current study, we first used an RNAscope in situ hybridization (ISH) method used in our 
previous studies [10,20,33] to determine whether incubation of methamphetamine craving is 
associated with activation of Drd1 and Drd2 in NAc core and shell, assessed by the activity marker 
Fos [34]. Next, we used site-specific reversible inactivation with GABAA and GABAB agonists 
(muscimol + baclofen [35]), Drd1-Drd2 antagonist (flupenthixol [36]) and selective Drd1 and Drd2 
receptor blockade with SCH39166 [37] and raclopride [38] to determine the causal role of these 
receptors in NAc core and shell in incubation of methamphetamine craving after food choice-induced 
voluntary abstinence. 
Materials and Methods 
Subjects, Surgery (intravenous and intracranial), Drugs, Intracranial injections, RNAscope in situ 
hybridization assay, Self-administration apparatus, Procedures, Palatable solution self-administration, 
Methamphetamine self-administration, Discrete choice procedure, Voluntary abstinence and Relapse 
test: see Supplemental Online Material.  
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Our procedures followed the guidelines of the national law (DL 26/2014) on the use of animals for 
research based on the European Communities Council Directive (2010/63/UE), and were approved 
by the ethics committee of the Italian Ministry of Health (license/approval ID #: 705/2018-PR) and by 
the local Ethical Committee of the Santa Lucia Foundation. 
Specific experiments 
Experiment 1: Fos expression in NAc core and shell during relapse tests after voluntary abstinence 
In experiment 1 (Exp. 1), we determined whether incubation of methamphetamine craving is 
associated with increased neuronal activity, as assessed by the activity marker Fos [39] in NAc core 
and shell. We also determined the cell type of the Fos-positive neurons in the two subregions by co-
labeling Fos with Drd1 and Drd2 [10,20,33,40]. We used four groups of rats (n=3–5/group) in an 
experimental design that included the between-subject factors of Test condition (no-test, relapse test) 
and Abstinence day (days 1 and 15). The experiment consisted of three phases: training, discrete 
choice voluntary abstinence, and relapse tests. 
Training. We first trained rats to self-administer first the palatable solution (sucrose 1% + 
maltodextrin 1%; SM 1%, 0.4 ml/reward delivery; 6 h/d, 6 d) and then methamphetamine (6 h/d, 12 d; 
0.1 mg/kg/infusion; 0.1 ml/infusion). The SM1% solution delivery and the methamphetamine infusions 
were paired with the presentation of 20-second discrete light cues (triple-light or white-light, 
respectively). 
Discrete choice procedure. We determined SM1% versus methamphetamine choice after every 
three consecutive drug self-administration sessions in all groups (three choice tests, during the 
training phase) and for 14 days (voluntary abstinence) preceding the abstinence day 15 relapse test. 
Relapse tests. We tested the rats for methamphetamine seeking under extinction conditions on 
abstinence days 1 or 15. The relapse tests were performed under extinction conditions in the 
presence of the house light. Active lever presses during testing, the operational measure of drug 
seeking in incubation of drug craving studies [13,14] resulted in contingent presentations of the white- 
light cue previously paired with methamphetamine, but not methamphetamine delivery. Immediately 
after the 60-minute relapse tests, we anesthetized the rats and processed their brains for the 
RNAscope in situ hybridization assay. For the no-test rats, we brought them to the perfusion room 
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from their home cage and perfused them on the same day and time as the relapse test rats. We 
matched the rats in the different groups for methamphetamine intake during the training phase. 
Exp. 2: Effect of the NAc core or shell muscimol + baclofen (M+B) inactivation on incubation of 
methamphetamine craving after voluntary abstinence 
We performed intravenous surgeries on the rats and implanted them with bilateral guide cannulas 
1 mm above the NAc core or shell (see SOM). The experimental procedure is identical to the one 
reported in Exp. 1, with the exception that we microinjected M+B in NAc before the relapse tests. We 
also habituated the rats to the injection procedure for 3 days during the discrete choice procedure.  
We used eight groups of rats (n=6–8/group) in an experimental design that included the between-
subject factors of Brain region (core, shell), Abstinence day (1, 15) and Muscimol + Baclofen dose 
(M+B; 0, 50 ng+50 ng/ 0.5 µl/side).  
Relapse tests. We determined the effect of reversible inactivation of the NAc core and shell on 
extinction responding on abstinence days 1 or 15. We injected bilaterally either vehicle (saline) or 
M+B (50 ng+50 ng/0.5 µl/side) into NAc core or shell 15 minutes before the 60-minute extinction test. 
Finally, to ensure that the effect of core inactivation by M+B on extinction responding during the late 
withdrawal test was not due to motor deficits, we re-trained 12 rats from the NAc core group to self-
administer the SM1% solution after they completed core injections and extinction tests on abstinence 
day 15. We re-trained them for 6 days (6 h/d) for the SM1% solution and then injected them vehicle or 
M+B (50 ng+50 ng/0.5 µl/side) into NAc core, 15 minutes before the 60-minute self-administration 
session. 
Exp. 3: Effect of NAc core SCH39166 or raclopride injections on incubation of methamphetamine 
craving  
In Exp. 1, we found selective time-dependent increases in Fos expression in NAc core, but not in 
shell, and that Fos was co-labeled with both Drd1 and Drd2. Moreover, in Exp. 2 we found a selective 
role of NAc core, but not shell. Based on these results, in Exp. 3 we determined the causal role of 
NAc core’s dopamine receptors in the incubation of methamphetamine craving after food choice-
induced voluntary abstinence. We used three groups of rats (n=6–8/group) in an experimental design 
that included the between-subject factors of Drug condition (vehicle, SCH39166, raclopride). We 
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excluded n=2 due to cannula’s misplacement. The experiment procedure is identical to the one 
reported in Exp. 2 (see SOM).    
Relapse tests. We tested rats for methamphetamine seeking under extinction conditions on 
abstinence day 15. We injected either the Drd1 antagonist SCH39166 (1.0 µg/0.5 µl/side) or the Drd2 
antagonist raclopride (1.0 µg/0.5 µl/side) into the core 15-min before testing. The length of the test 
session was 60 minutes. We matched the rats in the different groups for methamphetamine intake 
during the training phase. Finally, to verify that SCH39166 and raclopride, at the dose used in the 
relapse tests, do not non-selectively decrease operant responding, we re-trained 21 rats after the day 
15 testing to lever press for the SM1% for 6 h/d. After 6 days of training sessions, we injected the rats 
with vehicle (0.5 µl/side), SCH39166 (1.0 µg/0.5 µl/side) or raclopride (1.0 µg/0.5 µl/side) 10 minutes 
before the 60-minute test session. 
Exp. 4: Effect of NAc core flupenthixol injections on incubation of methamphetamine craving  
In Exp. 3, we found that a reversible pharmacological inactivation of Drd1 or Drd2 MSNs in the 
NAc core decreased methamphetamine seeking during late (day 15) abstinence. In both cases we 
observed about 60% reduction of drug-seeking responding. Based on these results, in Exp. 4 we 
determined whether by inactivating both Drd1 and Drd2 MSNs with the Drd1-Drd2 antagonist cis-(Z)-
Flupenthixol dihydrochloride (flupenthixol) will cause total suppression of methamphetamine seeking 
on day 15. In a separate group of rats we first determined the dose of flupenthixol, injected in the NAc 
core, that did not affect SM1% solution-reinforced responding, (see SOM).  
 We used two groups of rats (n=6–8/group) in an experimental design that included the between-
subject factors of dopamine antagonist condition (vehicle, flupenthixol). We excluded two rats due to 
cannula’s misplacement. The experiment procedure is identical to the one reported in Exp. 2 (see 
SOM). 
Relapse tests. We tested rats for methamphetamine seeking under extinction conditions on 
abstinence day 15. We injected either the vehicle or flupenthixol (10 µg/0.5 µl/side) into the core 15-
min before testing. The length of the test session was 60 minutes. We matched the rats in the 
different groups for methamphetamine intake during the training phase.  
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Statistical analysis 
Behavioral data. We analyzed the data with the statistical program SPSS Statistics using GLM 
module (IBM, version 23). For the self-administration training, we analyzed the amount of SM1% 
solution rewards and methamphetamine infusions separately with a repeated-measures ANOVA, 
using the within-subjects factor of Session. For the choice sessions during the training phase and the 
food choice-induced voluntary abstinence we analyzed the data with a repeated-measures ANOVA, 
using the within-subjects factors of Reward Type (SM1% solution or methamphetamine) and Choice 
Session.  
For the relapse test in Exp. 1 we analyzed active lever pressing using one-way ANCOVA with the 
between-subjects factor of Abstinence Day (1 or 15), and we included the inactive lever presses as 
covariate. For the relapse test in Exp. 2, we analyzed data using the between-subjects factors of 
Abstinence day (1 or 15) and M+B dose (0 or 50+50 ng). For the relapse tests in experiment 3-4, we 
used one-way ANCOVA with the between-subjects factors of dopamine antagonist condition (Exp. 3: 
vehicle, SCH39166, raclopride; Exp. 4: vehicle, flupenthixol) and the inactive lever presses were 
included as a covariate. For Exp. 2, 3 and 4, we also used a mixed ANOVA to analyze the 60-minute 
time course of active lever responding for day 15, using the between-subjects factor of Drug condition 
and the within-subjects factor of Session minutes (20, 40, 60). For the dose effect curve of 
flupenthixol, we analyzed the data using a repeated-measures ANOVA with the within-subject factor 
of flupenthixol Dose (0, 10, 20, 30 and 40 µg) and the Least Significant-Difference test for multiple 
comparisons. 
RNAscope and immunohistochemistry data. In Exp. 1 we analyzed the data with the between-
subjects factors of Abstinence Day (1 or 15) and Test Condition (test or no-test).  
In the Supplementary Online Material (SOM) we offer a summary of the statistical analysis. In the 
figures we only report significant effects that are critical for data interpretation. We followed up on 
significant main and interaction effects (p<0.05) using Fisher PLSD post-hoc tests. 
Results 
Exp. 1: Fos expression in NAc core and shell during relapse tests after voluntary abstinence 
The timeline of Exp. 1 is shown in Fig. 1A. 
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SM1% and methamphetamine training: The rats increased the rewards intake over sessions 
(Fig.1B) and extended daily access (6 hours/day) to methamphetamine led to escalation of drug 
intake [8,10]. The statistical analysis showed a significant effect of session for SM1% solution 
(F5,75=21.903, p<0.001) and methamphetamine (F11,165=20.5, p<0.001). During the three discrete 
choice sessions, the rats showed a strong preference for the SM1% solution (F1,15=164.2, p<0.001; 
Fig. 1C). 
Voluntary abstinence: During the 14 days of food choice-induced abstinence the rats showed a 
strong preference for the SM1% solution, with an almost complete suppression of the 
methamphetamine self-administration during the voluntary abstinence (Fig. 1D). The statistical 
analysis showed a significant effect of reward type (F1,7=259.1, p<0.001). 
Relapse test: Methamphetamine seeking in the extinction tests was higher at abstinence day 15 
than after 1 abstinence day, demonstrating incubation of methamphetamine craving after voluntary 
abstinence (Fig. 1E). The ANCOVA of active lever presses (inactive lever as covariate) showed a 
significant effect of Abstinence Day (F2,7=87.4, p<0.001). 
Fos and Fos + Drd1 or Drd2 RNAscope double-label data: Representative pictures of 
Fos/Drd1/Drd2 triple labeling by RNAscope in situ hybridization are shown in Fig. 1F. Fos expression 
in the relapse test was higher at abstinence day 15 relative to abstinence day 1 in NAc core but not in 
NAc shell. (Fig. 1G). The statistical analysis, which included the between-subjects factors of 
Abstinence Day and Test condition showed a main effect of both factors and the interaction between 
them for NAc core [Abstinence Day (F1,12=21.1, p=0.001); Test (F1,12=25.2, p<0.001); Abstinence Day 
X Test interaction (F1,12=13.5, p=0.003)]. We found no evidence for cell-type specificity of the 
activated (Fos-positive) NAc core neurons on abstinence day 15 (Fig. 1H, 1I upper and lower panels; 
for statistics refer to Supplementary Table 1).  
Exp. 2: Effect of the NAc core or shell muscimol + baclofen (M+B) inactivation on incubation of 
methamphetamine craving 
The timeline of the experiment is shown in Fig. 2A.  
SM1% solution and methamphetamine training: The rats increased the rewards intake over 
sessions (Fig. 2B). The statistical analysis showed a significant effect of session for SM1% solution 
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(F11,250=52.6, p<0.001) and methamphetamine (F11,550=81.2, p<0.001). During the three discrete 
choice sessions the rats showed a strong preference for the SM1% solution over methamphetamine 
that increased over time [Session (F2,100=6.6, p=0.002): Reward (F1,50=76.5, p<0.001); Reward X 
Session (F2,100=9.3, p<0.001; Fig. 2C)]. We did not observe differences between groups. 
Voluntary abstinence: During the 14 days of food choice-induced voluntary abstinence the rats 
showed a strong preference for the SM1% solution, with an almost complete suppression of 
methamphetamine self-administration during the voluntary abstinence that increased over time (Fig. 
2D). The statistical analysis showed a significant effect of Reward type (F1,26=596.7, p<0.001) and 
Session (F13,338=3.7,  p<0.001), and the interaction Reward X Session (F13,338=2.3, p=0.006).  
Relapse test: NAc core injections of M+B decreased methamphetamine seeking in the extinction 
tests on abstinence day 15 but not abstinence day 1 (Fig. 2E). The statistical analysis, which included 
the between-subjects factors of Abstinence Day and M+B dose, showed a main effect of the 
Abstinence Day (F1,22=27.2, p<0.001), M+B dose (F1,22=19.7, p<0.001) and interaction of Abstinence 
Day X M+B dose (F1,22=13.6, p=0.001). In contrast, shell injections of M+B had no effect on 
methamphetamine seeking in the extinction tests at abstinence day 15 and abstinence day 1 (Fig. 
2F).  
We also analyzed the time course of extinction responding on abstinence day 15 using the 
between-subject factors NAc Subregion and M+B dose, and the within-subject factor Session Time 
(20, 40 and 60 minutes; Fig. 2G). The statistical analysis showed a main effect of M+B dose 
(F1,27=16.2, p<0.001), Session Time (F2,27=28.6, p<0.001), NAc Subregion (F1,27=9.3, p=0.006) and 
interaction between the M+B dose and NAc Subregion (F1,27=6.4, p=0.018). 
Finally, to rule out that the NAc core effect was due to a motor deficit, we trained all the NAc core 
abstinence day 15 group to self-administer SM1% solution (Fig. S2B). We than determined the effect 
of vehicle or M+B injections into the NAc core on ongoing SM1% solution-reinforced responding: we 
found that M+B injections into NAc core had no effect on SM1% solution self-administration (F1,9=0.2, 
p=0.644) (Fig. S2C).  
Exp. 3: Effect of NAc core SCH39166 or raclopride injections on incubation of methamphetamine 
craving  
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The timeline of the experiment is shown in Fig. 3A.  
SM1% solution and methamphetamine training: The rats increased the rewards intake over 
sessions (Fig. S1B, left panel). The statistical analysis showed a significant effect of session for 
SM1% solution (F5,100=31.9, p<0.001) and methamphetamine (F11,220=25.0, p<0.001). During the 
three discrete choice sessions, the rats showed a strong preference for the SM1% solution 
(F1,20=40.8, p<0.001) (Fig. S1B, right panel). 
Voluntary abstinence: During the 14 days of food choice-induced abstinence the rats showed a 
strong preference for the SM1% solution (Fig. 3B). The statistical analysis showed a significant effect 
of reward type (F1,20=2611.2, p<0.001). 
Relapse test: NAc core injections of raclopride or SCH 39166 decreased methamphetamine 
seeking in the extinction tests at abstinence day 15 (F2,17=4.3, p<0.05; main effect of dopamine 
antagonist condition) (Fig. 3C). We also analyzed the time course of extinction responding using the 
between-subjects factor of dopamine antagonist condition and the within-subjects factor of Session 
(20, 40 and 60 minutes; Fig. 3D). The statistical analysis showed a main effect of the dopamine 
antagonist condition (F2,18=5.5, p<0.05), Session Time (F2,36=31.3, p<0.001) and an interaction 
between the dopamine antagonist condition and Session time (F4,36=6.6, p<0.001). 
Finally, to rule out that the effect was due to a motor deficit, we trained all the rats to self-
administer SM1% solution (Fig. S2D) and determined the effect of injections into the NAc core on 
ongoing SM1% solution-reinforced responding. We found that raclopride or SCH 39166 injections into 
NAc core had no effect on SM1% solution self-administration (F2,17=0.2, p=0.8) (Fig. S2E).  
Exp. 4: Effect of NAc core flupenthixol injections on incubation of methamphetamine craving  
The timeline of the experiment is shown in Fig. 3A.  
SM1% solution and methamphetamine training: The rats increased the rewards intake over 
sessions (Fig. S1C, left panel). The statistical analysis showed a significant effect of session for 
SM1% solution (F5,65=2.620, p<0.05) and methamphetamine (F11,143=3.422, p<0.05). During the three 
discrete choice sessions, the rats showed a strong preference for the SM1% solution (F1,13=10.3, 
p<0.01) (Fig. S1C, right panel). 
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Voluntary abstinence: During the 14 days of food choice-induced abstinence, the rats showed a 
strong preference for the SM1% solution (Fig. 3E). The statistical analysis showed a significant effect 
of reward type (F1,13=82.9, p<0.001). 
Relapse test: NAc core injections of flupenthixol decreased methamphetamine seeking in the 
extinction test at abstinence day 15 (F1,12=7.3, p= p<0.05; main effect of dopamine antagonist 
condition) (Fig. 3F). We also analyzed the time course of extinction responding using the between-
subjects factor of dopamine antagonist condition and the within-subjects factor of Time (20, 40 and 60 
minutes; Fig. 3G). The statistical analysis showed a main effect of Time (F2,24=13.0, p<0.001). 
The timeline of the dose effect curve of flupenthixol is shown in Fig. S3A. 
SM1% solution training: The rats increased the rewards intake over sessions (Fig. S3B). The statistical 
analysis showed a significant effect of session for SM1% solution (F4,24=9.0, p<0.01). 
Dose effect curve: Flupenthixol dose dependently decreased SM1% solution reinforced responding (Fig. 
S3C). The statistical analysis showed a significant effect of Dose  (F4,24=8.7, p<0.01). A post hoc analysis 
conducted with the Least Significant-Difference test revealed a significant difference between saline and 
the doses of flupenthixol of 30 and 40 g/side and a nearly significant effect at the dose of 20 g/side. 
Discussion 
There are three main findings in our study. First,  incubation of methamphetamine craving was 
associated with increased Fos expression in NAc core Drd1- and Drd2-MSNs after 15 abstinence 
days; in contrast we did not found any increased Fos expression in the NAc shell subregion. Second, 
reversible inactivation of NAc core selectively decreased methamphetamine seeking during late (day 
15) but not early (day 1) abstinence. This effect was selective to methamphetamine seeking, 
muscimol + baclofen injections had no effect on SM1% solution-reinforced responding test. Third, 
blockade of Drd1-, Drd2- or both Drd1-Drd2-family receptors in NAc core decreased incubated (day 
15) methamphetamine craving after voluntary abstinence to a similar extent. Together, our results 
indicate that dopamine transmission through Drd1 and Drd2 in activated NAc core is critical to the 
incubation of methamphetamine craving after food choice-induced voluntary abstinence. 
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Methodological considerations 
A number of methodological issues should be considered in the interpretation of the present data. 
The first issue is represented by the specificity of the inactivating effect of muscimol + baclofen on NAc 
core. It is unlikely that this effect was due to non-specific performance deficits, as muscimol + baclofen 
had no effect on lever presses during abstinence day 1 or high-rate operant responding for the palatable 
solution (sucrose 1% + maltodextrin 1%) (see Results and Fig. 2E-S2C). Similarly, it is unlikely that the 
effect of SCH39166 and raclopride NAc core injections was due to non-specific performance deficits. This 
is because we used a dose that had no effect on operant responding for the palatable food (%) (see 
Results and Fig. S2E). In this context, it is important to emphasize that depletions of NAc dopamine do 
not substantially impair all aspects of primary food motivation and that NAc infusions of dopamine 
antagonists at doses that impair runway performance did not impair sucrose intake (for reviews [41,42]).  
The second methodological issue is represented by the anatomical specificity of the intracranial 
injections. It is unlikely that the behavioral changes were due to drug diffusion from the injection site 
[43], because injections into NAc shell had no effect on incubated methamphetamine craving after 
food choice-induced voluntary abstinence (see Results and Fig. 2F). A third methodological 
consideration is that we used only male rats in this study. In this regard, several studies demonstrated 
sex differences in psychostimulant self-administration and relapse, including incubation of cocaine 
craving after forced abstinence [44,45], and reinstatement of methamphetamine seeking [46]. 
However, it is unlikely that female rats would have responded differently to our manipulations. In our 
previous studies, we found no evidence for sex differences in methamphetamine self-administration, 
or in the strong preference for the palatable food over methamphetamine or the magnitude of 
incubated methamphetamine seeking after either forced or voluntary abstinence [11]. The fourth 
methodological issue concerns the muscimol+baclofen effect on methamphetamine seeking. We only 
observed an effect of the two agonists on abstinence day 15 but not day 1, suggesting a selective 
effect on ‘incubated’ cue-induced drug seeking. However, this selective time-dependent effect should 
be interpreted with caution because of a potential floor effect due to low responding on day 1. 
Finally, from a brain mechanism perspective, we did not investigate the role of dopamine 
transmission in the NAc shell in the incubation of methamphetamine craving after voluntary 
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abstinence because we did not observe neither a time-dependent increase in Fos expression after 
the relapse tests on abstinence days 1 and 15 (see Results and Fig. 1G, lower panel) nor an 
attenuation of incubated craving after the reversible inactivation with muscimol + baclofen (see 
Results and Fig. 2F). However, these correlational and causal data do not definitively rule out a role 
of NAc shell dopamine transmission in the incubation of methamphetamine craving because previous 
studies have demonstrated dissociable effects of reversible inactivation relative to dopamine or 
glutamate receptors blockade [47]. 
The role of nucleus accumbens core in incubation of methamphetamine craving after 
voluntary abstinence 
The NAc core and shell are heterogeneous structures distinguished on the basis of the 
morphology and projections [48,49]. These neuroanatomical evidences stimulated a large number of 
studies on the role of NAc core and shell in motivated behavior [50,51] and conditioned and 
unconditioned rewarding effects of drugs [52,53]. Our results from Exp. 1 and 2, supporting a role for 
the NAc core but not shell in incubation of methamphetamine craving after voluntary abstinence, are 
in agreement with the general notion that NAc core and shell mediate distinct aspects of drug-
motivated behaviors [54]. In particular, they are in agreement with previous findings where permanent 
lesions or reversible inactivation (muscimol + baclofen) of core but not shell decrease discrete-cue-
induced reinstatement of cocaine [55,56] and methamphetamine seeking [57] and discrete-cue-
induced cocaine seeking, as assessed in an acquisition of a new response procedure [58].  
Our results provide further correlational evidences of altered firing in the NAc core during 
incubation of cocaine craving after forced abstinence [22,23]. This altered firing is putatively 
associated with the higher conductance expressed by the CP-AMPARs (homomeric GluA1 receptors) 
that accumulate in the NAc core over time [24,59]. Consistent with these findings, incubated cocaine 
and methamphetamine craving after forced abstinence was reduced by decreasing CP-AMPARs 
transmission in NAc core [24-26] or, for cocaine, via weakening the prelimbic cortex to NAc core 
pathway [27].  
Levels of CP-AMPARs are also elevated in the NAc shell after incubation of cocaine craving 
[27,29,31] and CP-AMPARs transmission in the NAc shell play a causal role in incubation of cocaine 
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craving. These latter evidences are at odds with our data. In Exp. 1 (RNAscope in situ hybridization 
for Fos) and Exp. 2 (muscimol + baclofen inactivation) we did not observe any appreciable increase in 
Fos expression (marker of neuronal activity) nor an appreciable reduction in incubated 
methamphetamine craving after voluntary abstinence. What may account for this discrepancy? The 
answer is not straightforward because a direct comparison of our study and Dong and colleagues’ 
studies [27,31] is not possible for two main reasons: 1) we used methamphetamine while Dong and 
colleagues used cocaine. In the case of NAc core, both incubation to cocaine and methamphetamine 
have been shown to result in CP-AMPARs in the core. However, we do not know if incubation to 
methamphetamine results in CP-AMPARs in the shell; 2) we used an extended drug-self 
administration procedure for 12 days (6 h/day) and voluntary abstinence in adult rats, while Dong and 
colleagues used a single overnight training session plus short-access procedure for 5 days (2 h/day) 
and forced abstinence in juvenile rats. It is well established that the neural adaptions occurring during 
an extended-access relative to short-access self-administration are distinct [60] and that juvenile 
onset and adult onset self-administration are associated with different physiological and behavioral 
changes [61,62].  
Finally, the neuroanatomical substrates responsible for the expression of incubated 
methamphetamine craving, identified in this (NAc core but not shell) and previous studies (CeA but 
not BLA; [20,63]), mirror the neuroanatomical substrates involved in the expression of the ‘general’ 
form of Pavlovian to Instrumental Transfer (PIT) [64], which is thought to represent the general 
motivational or affective properties of the reward [65]. First proposed by Li and colleagues [63], our 
findings support the hypothesis that incubation of drug craving may be due to time-dependent 
increases in the motivational potency of Pavlovian drug associated cues after abstinence that is 
mediated by increased activity of CeA and NAc core during the late abstinence relapse tests. The 
common role of CeA [20,63] and NAc core in promoting incubation of methamphetamine craving 
suggests that these regions, with no direct anatomical connections [66] interact functionally during the 
drug seeking test. As previously speculated for PIT [64], the CeA may indirectly recruit the NAc core 
via its projections to ventral tegmental area, which projects to NAc core [66].  
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Role of NAc Drd1- and Drd2-MSNs during incubation of methamphetamine-craving after 
voluntary abstinence 
The mesolimbic dopamine system innervating the NAc is critically involved in cue-elicited 
reinstatement of drug-seeking [67]. However, relatively little is known on the role of NAc-dopamine 
transmission in incubation of cue-induced drug craving after prolonged forced and voluntary abstinence. 
Ito et al., [68] first reported that cocaine-associated cues significantly increase extracellular dopamine in 
the NAc core (see Willuhn for a review and conflicting findings [69]), suggesting that enhanced dopamine 
transmission may be involved in cue-induced craving and relapse to drug seeking. Subsequently, a 
seminal study by Ciccocioppo et al. [70], showed that systemic blockade of Drd1 decreases both 
discriminative cue-induced reinstatement and discriminative cue-induced Fos and that the reinstatement 
effect of the discriminative cues persists for at least 4 months after cocaine exposure [70]. These 
investigators also demonstrated that the response to the cocaine-associated discriminative cues is 
remarkably persistent over repeated testing and that Drd2 play a role in this form of reinstatement [71]. 
Since then, several studies employing Drd1 and Drd2 partial agonists and antagonists have been shown 
to reduce cue-induced drug seeking (reviewed in [72]).  
Overall, the effect of selective Drd1 and Drd2 (SCH39166 and raclopride) or both Drd1-Drd2 
(flupenthixol) antagonists reported here confirm earlier findings and suggest that the incubation of 
methamphetamine-seeking after voluntary abstinence is not dependent of a specific subtype of MSNs. 
Furthermore, our data do not support the hypothesis that Drd1 and Drd2 MSNs act in opposing manner 
[73] but rather, suggests that a coincident and concerted MSNs activity is required for reward-related 
behaviors [74-76]. Indeed, regardless of the antagonist used in our experiments (SCH39166, Drd1-
selective; raclopride, Drd2-selective; flupenthixol, Drd1-Drd2-selective), we observed reliable reduction of 
incubation of methamphetamine craving.  
Our data are also consistent with our previous results on incubation of methamphetamine seeking 
after forced and voluntary abstinence. Indeed, in these studies the incubation-sensitive Fos-positive 
neurons (activated after periods of forced or voluntary abstinence) in the dorsomedial and dorsolateral 
striatum co-expressed both Drd1 and Drd2 [10,77]. Furthermore, studies employing extended-access 
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cocaine regimens leading to incubation of cocaine craving support the idea that there is a similar plasticity 
in Drd1- and Drd2-expressing MSNs in NAc core [78] or even in the dorsal striatum [79]. An important 
example is the elevation of CP-AMPAR levels that is observed in nearly all NAc core MSNs after 
extended-access cocaine self-administration and after a month of abstinence, albeit in a pathway-specific 
manner [59,78]. 
Conclusions 
We used our recently developed choice-based rat model of drug relapse after voluntary 
abstinence that mimics the human condition of relapse after successful contingency management. 
Here we used RNAscope in situ hybridization and pharmacological approaches to show a critical role 
of Drd-1 and Drd2-mediated NAc core neuronal activity in the expression of incubation of 
methamphetamine craving after food choice-induced voluntary abstinence. 
To the degree that our choice-based model of drug relapse in rats mimics the human condition of 
relapse after successful contingency management, our findings suggest the NAc core as a potential 
target for relapse prevention. 
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Figure Legends 
Figure 1. Incubation of methamphetamine craving is associated with activation of NAc core but 
not shell: behavioral data and RNAscope data. (A) Timeline of the experiment (Exp.1). The self-
administration chamber is equipped with two active levers (SM1% and methamphetamine), one 
inactive lever, one discriminative stimulus (yellow house light), two conditioned stimuli (white light for 
methamphetamine, triple-light for SM1%), two pumps (one for SM1%, one for methamphetamine), a 
liquid receptacle (B) Self-Administration training. Mean ± SEM number of SM1% rewards (0.4 
ml/reward) or methamphetamine infusions (0.1 mg/kg/infusion; 0.1 ml/infusion) during the 6-hour 
sessions, n=16. (C) Choice sessions during training. Mean ± SEM number of SM1% rewards and 
methamphetamine infusions earned during the three discrete choice sessions during training (20 
trials every 10 minutes), n=16. (D) Voluntary abstinence. Mean ± SEM number of SM1% rewards and 
methamphetamine infusions earned during 14 discrete choice sessions, n=10. (E) Relapse tests. 
Mean ± SEM number of lever presses on active, non-reinforced, and inactive levers during the 60-
minute test sessions. (F) Representative photomicrographs of the NAc core and NAc shell and Fos 
and Drd1 or Drd2 labeling in the relapse-test and no-test groups. (Fos, white; Drd1, green; Drd2, red; 
DAPI, blue). Arrows indicate representative cells. (G) Fos neurons quantification. Number of Fos-IR 
(immunoreactivity) nuclei per mm2 in NAc core (top panel) and shell (bottom panel). (H) Fos-IR co-
expression with Drd1 cells in NAc core (top panel) and shell (bottom panel). (I) Fos-IR co-expression 
with Drd2 cells in NAc core (top panel) and shell (bottom panel). * p<0.05 different from day 1. Circles 
represent individual data, n=16, 3-5/group. 
Figure 2. Reversible inactivation of NAc core but not shell decreased incubated 
methamphetamine seeking after voluntary abstinence. (A) Timeline of the experiment (Exp.2). (B) 
Self-administration training. Mean ± SEM number of SM1% rewards or methamphetamine infusions 
during the 6-hour sessions in rats with implanted cannula in the NAc core (Core) or NAc shell (Shell), 
n=52. (C) Choice sessions during training. Mean ± SEM number of SM1% rewards and 
methamphetamine infusions earned during the three discrete choice sessions during training in Core 
and Shell rats, n=52. (D) Voluntary abstinence. Mean ± SEM number of SM1% rewards and 
methamphetamine infusions earned during 14 discrete choice sessions from the voluntary abstinence 
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group tested on abstinence day 15, n=28. (E-F) Relapse tests for muscimol + baclofen (M+B) 
injections into NAc core and shell. Mean ± SEM number of lever presses on active, non-reinforced 
lever during the 60-minute test sessions on day 1 (n=24) or day 15 (n=28) of voluntary abstinence. 
We injected vehicle or M+B (50 ng+50 ng/0.5 l/side) into NAc core or shell 15 minutes before the 60-
minute extinction tests. We added a representative photomicrograph of the cannula placement in the 
area (scale bar, 500 m). * p<0.05 different from day 1. (G) Time course of lever presses during the 
relapse test on day 15. Mean ± SEM number of lever presses on active, non-reinforced lever during 
different time periods of the relapse test (0-20, 20-40, 40-60 min) (n=28). (H-I) Cannula placement in 
NAc core or shell. Approximate placement (mm from bregma) of the injector tips [80]. Vehicle: open 
circles; M+B: closed circles).  
Figure 3. Drd1, Drd2 or Drd1-Drd2 antagonists’ injection into NAc core decreased relapse after 
voluntary abstinence. (A) Timeline of the experiments (Exp.3 and 4). (B) Voluntary abstinence Exp.3 
(raclopride or SCH 39166). Mean ± SEM number of SM1% rewards and methamphetamine infusions 
earned during 14 discrete choice sessions. (C) Relapse test for raclopride or SCH 39166 injections 
into NAc core (Exp.3). Mean ± SEM number of lever presses on active, non-reinforced, and inactive 
levers during the 60-minute test sessions on day 15 of voluntary abstinence. We injected vehicle or 
raclopride (1.0 µg/0.5 l/side) or SCH 39166 (1.0 µg/0.5 l/side) into NAc core 15 minutes before the 
60-minute extinction tests. We added a representative photomicrograph of the cannula placement in 
the area (scale bar, 500 mm). (D) Time course of lever presses during the relapse test on day 15 
(Exp.3).  Mean ± SEM number of lever presses on active, non-reinforced lever during different time 
periods of the relapse test (0-20, 20-40, 40-60 min). (E) Voluntary abstinence Exp.4 (flupenthixol). 
Mean ± SEM number of SM1% rewards and methamphetamine infusions earned during 14 discrete 
choice sessions. (F) Relapse test for flupenthixol injections into NAc core (Exp.4). Mean ± SEM 
number of lever presses on active, non-reinforced, and inactive levers during the 60-minute test 
sessions on day 15 of voluntary abstinence. We injected vehicle or flupenthixol (10 µg/0.5 µl/side) into 
NAc core 15 minutes before the 60-minute extinction test. We added a representative 
photomicrograph of the cannula placement in the area (scale bar, 500 mm). (G) Time course of lever 
presses during the relapse test on day 15 (Exp.4).  Mean ± SEM number of lever presses on active, 
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non-reinforced lever during different time periods of the relapse test (0-20, 20-40, 40-60-minute). (H) 
Cannula placement in NAc core (Exp.3). Approximate placement (mm from bregma) of the injector 
tips [80]. Vehicle: open circles; raclopride: closed squares; SCH 39166: open triangles). (I) Cannula 
placement in NAc core (Exp.4). Approximate placement (mm from bregma) of the injector tips [80]. 
Vehicle: open circles; flupenthixol: closed circles). Exp.3 (n=21, 6-8/group); Exp.4 (n=14, 7/group). * 
p<0.05 different from saline. 
 
 
